ChemoCare

by CIS Oncology
VISIT OFFICIAL WEBSITE →
Disclaimer: This page is an independent third-party listing and is not affiliated with, sponsored by, or endorsed by ChemoCare or CIS Oncology. All product names, logos, and brands are property of their respective owners.

OVERVIEW

The UK's leading electronic chemotherapy prescribing and patient management system used by 80% of NHS centers.

ChemoCare, developed by CIS Oncology (now part of System C), is a comprehensive electronic chemotherapy prescribing and patient management system. It is the number-one-selling system in the UK, widely adopted by NHS trusts across England, Scotland, and Wales. The software is designed to enhance patient safety, standardize treatment, and streamline clinical workflows.

Product Overview & Key Benefits: ChemoCare integrates the entire systemic anti-cancer treatment (SACT) process—from prescribing to preparation, administration, and scheduling—onto a single, easily accessible platform. This integration ensures seamless data-sharing, instant access to patient records from multiple locations, and the elimination of errors in dosage calculation and drug reconstitution. The system is flexible and can be adapted for use in both large hospitals and smaller satellite centers, helping to manage increasing patient demands and complex treatment regimens.

Main Features & Capabilities:

  • Prescribing: Comprehensive support for adult oncology and haematology, as well as specialised paediatric oncology and haematology prescribing.
  • Drug Preparation (ChemoWS): Precise drug preparation with customisable worksheets and labels to improve safety and save time.
  • Scheduling (ChemoSchedule): Integrated scheduling for treatment, appointments, and ad-hoc interventions, helping to increase patient capacity.
  • Patient Engagement (ChemoPRO): An innovative mobile app that empowers patients with instant access to their medical information and facilitates quick communication with healthcare professionals.
  • Data & Research: Advanced data mining capabilities to streamline data collection for clinical studies, Real World Evidence (RWE), and clinical audit/financial monitoring.

Target Users & Use Cases: ChemoCare is primarily used by oncologists, pharmacists, and nurses within NHS trusts and other healthcare facilities. Its core use cases are standardizing and safely prescribing SACT, streamlining pharmacy workflows, coordinating patient treatment schedules, and supporting medical research through efficient data access.

RATING & STATS

Customers
100+
Founded
1996

KEY FEATURES

  • Electronic Chemotherapy Prescribing (Adult & Paediatric)
  • Integrated Patient Management System
  • Precise Drug Preparation Worksheets (ChemoWS)
  • Treatment and Appointment Scheduling (ChemoSchedule)
  • Patient Empowerment Mobile App (ChemoPRO)
  • Seamless Clinical Data Sharing & Integration
  • Clinical Audit and Financial Monitoring
  • Data Mining for Clinical Studies & RWE

PRICING

Model: enterprise
Pricing is not publicly disclosed and is based on an enterprise license model, typical for large-scale deployments across NHS Trusts and hospital networks.

TECHNICAL DETAILS

Deployment: saas, cloud
Platforms: web, ios, android
📱 Mobile Apps🔌 API Available

USE CASES

Standardizing and safely prescribing Systemic Anti-Cancer Treatment (SACT)Streamlining pharmacy preparation and labellingCoordinating patient appointments and treatment schedulesFacilitating clinical research and Real World Evidence (RWE) collection

INTEGRATIONS

System C CareFlow EPRCareFlow Medicines ManagementOther Clinical Systems (via data-sharing)

COMPLIANCE & SECURITY

Compliance:
ISO 27001ISO 13485ISO 9001Cyber Essentials PlusGDPR
Security Features:
  • 🔒Built-in safety features to prevent dosage errors
  • 🔒Data encryption (implied by ISO 27001 and secure hosting)

SUPPORT & IMPLEMENTATION

Support: email, phone, knowledge_base, training
Target Company Size: medium, enterprise
TRAINING AVAILABLE

PROS & CONS

✓ Pros:
  • +UK's leading and widely adopted system (80% NHS coverage).
  • +Mitigates clinical risk with built-in safety features for dosage and preparation.
  • +High-level security and compliance (ISO 27001, ISO 13485, GDPR).
  • +Integrated platform for prescribing, preparation, and scheduling.
  • +Supports clinical research and Real World Evidence (RWE) data mining.
✗ Cons:
  • -Pricing is not transparent (enterprise model).
  • -UK-centric design and compliance may limit international adoption.
  • -Potential steep learning curve (implied by extensive training program).

ABOUT CIS ONCOLOGY

BROWSE SOFTWARE IN ORAL CHEMOTHERAPY MANAGEMENT